NewsRx

Search our medical news database

Decision Resources

Report announces leader in neurology drug market

Published in Mental Health Business Week, April 24th, 2004

Decision Resources, Inc., finds that Pfizer continues to dominate the neurology drug market with 37% market share.

The report, entitled "Neurology Pipeline Analysis: Top Companies Maintain Position Through 2007," notes that Pfizer has a drug in each neurology category discussed - Alzheimer disease, Parkinson disease, multiple sclerosis, and epilepsy.

"Although Pfizer will remain the leader in the neurological drug market in 2007, Johnson & Johnson (J&J) and Novartis will also become key players in this therapeutic area, capturing 12% and 11% of the market, respectively, said Heather Martin, analyst at Decision Resources.

"J&J's...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Mental Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook